39633-82-4

Basic information

• Product Name: (1,4'-Bipiperidine)-4'-carboxamide
• Synonyms: (1,4'-BIPIPERIDINE)-4'-CARBOXAMIDE;4-(1-PIPERIDINO)-4-PIPERIDINECARBOXAMIDE;(1,4'-Bipiperidine)-4'-carboxamide, 99+%;1,4'-Bipiperidinyl-4'-carboxaMide;4-(1-Piperidinyl)-4-(aMinocarbonyl)piperidine;4-CarbaMoyl-4-(1-piperidinyl)piperidine;NSC 76044;4-(1-piperidyl)-4-piperidinecarboxamide
• CAS NO: 39633-82-4
• Molecular Formula: C₁₁H₂₁N₃O
• Molecular Weight: 211.3
• EINECS: 254-548-2
• Product Categories: Amines;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 39633-82-4.mol
• Article Data: 1

Chemical Properties

• Melting Point: 129-132 °C
• Boiling Point: 351°C (rough estimate)
• Flash Point: 188.7 °C
• Appearance: white powder
• Density: 1.0221 (rough estimate)
• Refractive Index: 1.5700 (estimate)
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 16.23±0.20(Predicted)
• CAS DataBase Reference: (1,4'-Bipiperidine)-4'-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: (1,4'-Bipiperidine)-4'-carboxamide(39633-82-4)
• EPA Substance Registry System: (1,4'-Bipiperidine)-4'-carboxamide(39633-82-4)

Safety Data

• Hazard Codes: C,Xn
• Statements: 34-22-36/37/38-20/21/22
• Safety Statements: 45-36/37/39-26-36
• Hazardous Substances Data: 39633-82-4(Hazardous Substances Data)

Usage

Chemical Properties

white powder

Downstream Products

• 1026665-95-1 1'-{[5-(4-chlorophenyl)-4-(2,4-dichlorophenyl)-1-{3-[(methylsulfonyl)amino]-propyl}-1H-pyrrol-2-yl]carbonyl}-1,4'-bipiperidine-4'-carboxamide 
• 1026665-91-7 C₃₁H₃₅Cl₃N₄O₄S 
• 1893-33-0 pipamperone 
• 1026665-89-3 C₃₁H₃₂Cl₃N₅O₂ 
• 1026666-10-3 1'-[5-(4-chlorophenyl)-4-(2,4-dichlorophenyl)-1H-pyrrole-2-carbonyl]-1,4'-bipiperidinyl-4'-carboxamide 
• 134200-76-3 1'-(6-Benzyl-4-oxo-3,4,5,6,7,8-hexahydro-pyrido[4,3-d]pyrimidin-2-yl)-[1,4']bipiperidinyl-4'-carboxylic acid amide 

Relevant articles and documents

Substituted heterocycles

Compounds of formula I STR1 wherein Q1, Q2, Q3, Q4 and Q5 have any of the meanings given in the specification, their N-oxides, and their pharmacuetically acceptable salts are nonpeptide antagonists NKA, useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.